Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347656 · ClinicalTrials.gov registry record
Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 164
- Enrollment target
NCT03347656 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 164 participants.
The verdict
NCT03347656 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) predicts discharge disposition, 90 day Barthel Index and other outcomes like muscle wasting (expressed as decrease in rectus femoris cross sectional area (RF-CSA) in the paretic and non-paretic limb measured by bedside ultrasound), and ICU length of stay (LOS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2017-10-12 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347656
The ClinicalTrials.gov registry entry for NCT03347656 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03347656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03347656 about?
NCT03347656 is a clinical study titled "Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients". The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) pr...
What is the current status of trial NCT03347656?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2017-10-12. Estimated completion is 2021-06-30.
Who is sponsoring clinical trial NCT03347656?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.